Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by ATSUSHI NAGASE
Feasibility of Adjuvant Chemotherapy With S-1 Consisting of a 4-Week Administration and a Two-Week Rest Period in Patients With Completely Resected Non-Small Cell Lung Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program
Clinical Cancer Research
Cancer Research
Oncology
Feasibility and Efficacy of Adjuvant Chemotherapy With a Split-Dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients With Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer -A Retrospective Analysis-
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy for Patients With Completely Resected Advanced Lung Cancer: A Multicenter Randomized Controlled Trial
BMC Cancer
Cancer Research
Oncology
Genetics
P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma
Comparison of Concurrent Chemoradiotherapy Versus Sequential Radiochemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer
Radiation Oncology Journal
Oncology
Radiology
Nuclear Medicine
Imaging
Adjuvant Therapy for Resected Non–Small-Cell Lung Cancer With Lymphovascular Invasion
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Neutrophil-Lymphocyte Ratio Predicts Recurrence in Patients With Resected Stage 1 Non-Small Cell Lung Cancer
Journal of Cardiothoracic Surgery
Cardiology
Cardiovascular Medicine
Medicine
Pulmonary
Respiratory Medicine
Surgery